Literature DB >> 18936344

Patients with renal dysfunction require a longer duration until blood pressure dips during the night.

Michio Fukuda1, Masashi Mizuno, Tamaki Yamanaka, Masahiro Motokawa, Yuichi Shirasawa, Takae Nishio, Sota Miyagi, Atsuhiro Yoshida, Genjiro Kimura.   

Abstract

We have postulated that the diminished renal capacity to excrete sodium causes nocturnal blood pressure (BP) elevation, which enhances pressure natriuresis in compensation for impaired daytime natriuresis. If such a mechanism holds, high BP during sleep at night may continue until excess sodium is sufficiently excreted into urine. This study examined whether the duration, defined as "dipping time," until nocturnal mean arterial pressure began to fall to <90% of daytime average became longer as renal function deteriorated. Ambulatory BP measurements and urinary sodium excretion rates were evaluated for daytime and nighttime to estimate their circadian rhythms in 65 subjects with chronic kidney disease. Dipping time showed an inverse relationship with creatinine clearance (C(cr); rho=-0.61; P<0.0001) and positive relationships with night/day ratios of mean arterial pressure (rho=0.84; P<0.0001) and natriuresis (rho=0.61; P<0.0001), both of which were also inversely correlated with C(cr) (mean arterial pressure: r=-0.58, P<0.0001; natriuresis: r=-0.69, P<0.0001). When divided into tertiles by C(cr) (mL/min), hazard ratios of nocturnal BP dip adjusted for age, gender, and body mass index were 0.37 (95% CI: 0.17 to 0.79; P=0.01) for the second tertile (C(cr): 50 to 90) and 0.20 (95% CI: 0.08 to 0.55; P=0.002) for the third tertile (C(cr): 5 to 41) compared with the first tertile (C(cr): 91 to 164). These findings demonstrate that patients with renal dysfunction require a longer duration until BP falls during the night. The prolonged duration until BP dip during sleep seems an essential component of the nondipper pattern of the circadian BP rhythm.

Entities:  

Mesh:

Year:  2008        PMID: 18936344     DOI: 10.1161/HYPERTENSIONAHA.108.115329

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.

Authors:  Wai W Cheung; Wei Ding; Sujana S Gunta; Yong Gu; Rinat Tabakman; Leah N Klapper; Arieh Gertler; Robert H Mak
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

Review 2.  Circadian regulation of kidney function: finding a role for Bmal1.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

3.  Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.

Authors:  Kotaro Haruhara; Nobuo Tsuboi; Kentaro Koike; Akira Fukui; Yoichi Miyazaki; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Hypertens Res       Date:  2014-09-18       Impact factor: 3.872

4.  Salt sensitivity and nondippers in chronic kidney disease.

Authors:  Michio Fukuda; Genjiro Kimura
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 5.  Diurnal Regulation of Renal Electrolyte Excretion: The Role of Paracrine Factors.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Annu Rev Physiol       Date:  2019-10-21       Impact factor: 19.318

Review 6.  Regulation of circadian blood pressure: from mice to astronauts.

Authors:  Rajiv Agarwal
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

7.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

8.  Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.

Authors:  Shinsuke Isobe; Naro Ohashi; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2014-04-12       Impact factor: 2.801

9.  The natriuretic effect of angiotensin receptor blockers is not attributable to blood pressure reduction during the previous night, but to inhibition of tubular sodium reabsorption.

Authors:  Toshiyuki Miura; Shuichi Watanabe; Maki Urushihara; Hiroyuki Kobori; Michio Fukuda
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-05-15       Impact factor: 1.636

10.  Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption.

Authors:  Michio Fukuda; Maki Urushihara; Tamaki Wakamatsu; Tadashi Oikawa; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-07       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.